KEW Group's Series A Round

KEW Group raised a round of funding on February 26, 2014.

KEW Group provides evidence based therapeutic pathways to oncology practices. EW Group's CLIA Certified laboratory has launched KEW CancerPlex, a highly versatile and comprehensive gene testing panel …

Articles about KEW Group's Series A Round: